Journal article

Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma

SL Chua, JF Seymour, J Streater, MM Wolf, EH Januszewicz, HM Prince

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2002

DOI: 10.1080/1042819021000006475

Citation metrics

55Web of Science
55Scopus
57Dimensions

Keywords

Time Factors
Non-Hodgkin'S Lymphoma
International Prognostic Index Score
Dose Intravenous Methotrexate
Science & Technology
Acute Lymphocytic-Leukemia
Cns Prophylaxis
Intrathecal Chemotherapy
Female
Prognosis
Risk-Factors
Treatment Outcome
Life Sciences & Biomedicine
Meningeal Leukemia
Cerebrospinal-Fluid
Middle Aged
Humans
Risk Factors
Adult
Methotrexate
Single-Center
Antibiotics, Antineoplastic
Leptomeningeal Carcinomatosis
Central Nervous System Neoplasms
Oncology
Standard Regimen Chop
Aged
Lymphoma, Non-Hodgkin
Aged, 80 and Over
M-Bacod
Male
Adolescent
Injections, Spinal
Hematology
Prognostic Factors
Secondary Prevention